Early pregnancy termination with mifepristone and misoprostol in Norway

Acta Obstetricia et Gynecologica Scandinavica

Volumn 80, Issue 11, 2001, Pages 1056-1061

  Bjorge L ^a   Johnsen, S L ^a   Midboe G ^a   Augestad, G ^a   Okland I ^a   Helland, H ^a   Stray Pedersen, S ^a   Iversen, O E ^a  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Antiprogestin; Pregnacy termination; Prostaglandin analog

Indexed keywords

MIFEPRISTONE; MISOPROSTOL;

ABDOMINAL PAIN; ADOLESCENT; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG USE; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; MAJOR CLINICAL STUDY; NORWAY; PATIENT SATISFACTION; PREGNANCY TERMINATION; PRIORITY JOURNAL; THERAPEUTIC ABORTION; VAGINA BLEEDING;

ABORTIFACIENT AGENTS, NONSTEROIDAL; ABORTIFACIENT AGENTS, STEROIDAL; ABORTION, INDUCED; ACETAMINOPHEN; ADOLESCENT; ADULT; ANALGESICS, NON-NARCOTIC; ANALGESICS, OPIOID; CODEINE; FEMALE; HUMANS; MIFEPRISTONE; MISOPROSTOL; NORWAY; PAIN MEASUREMENT; PATIENT SATISFACTION; PREGNANCY; PREGNANCY TRIMESTER, FIRST; TREATMENT OUTCOME;

EID: 17944365841     PISSN: 00016349     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0412.2001.801118.x     Document Type: Article

References (38)

1. Medical abortion still not available in most countries
2. Comparison of medical abortion with surgical vacuum aspiration: Women's preferences and acceptability of treatment
3. A comparison of medical and surgical termination of pregnancy: Choice, emotional impact and satisfaction with care
4. Medical abortion or vacuum aspiration? Two year follow up of a patient preference trial
5. Side effects of mifepristone-misoprostol abortion versus surgical abortion. Data from a trial in China, Cuba, and India
6. The efficacy of medical abortion: A meta-analysis
7. Political, economic and ethical aspects of use of medical abortifacients
8. Clinical use of mifepristone (RU 486)
9. Mifepristone (RU 486): Current knowledge and future prospects
10. RU 486, mifepristone: A review of a controversial drug
11. Fear of black market means no RU-486 for Canada until US approves drug
12. German drug agency approves mifepristone
13. Clinical pharmacokinetics of mifepristone
14. Medical termination of pregnancy
15. Medical options for early pregnancy termination
16. Bør antiprogesterone bruk i norge?
17. Provosert abort
18. Early termination of pregnancy with mifepristone (RU 486) and the orally active prostaglandin misoprostol
19. Induction of abortion with mifepristone and misoprostol in early pregnancy
20. Outcomes of suction curettage and mifepristone abortion in the United States. A prospective comparison study
21. Medical versus surgical abortion
22. WHO Task Force on Post-ovulatory Methods of Fertility Regulation. Termination of pregnancies with reduced doses of mifepristone
23. An effective regimen for early medical abortion: A report of 2000 consecutive cases
24. Termination of early pregnancy (up to 63 days of amenorrhea) with mifepristone and increasing doses of misoprostol
25. Termination of pregnancy at 9-13 weeks' amenorrhoea with mifepristone and misoprostol
26. Limb deficiency with or without Mobius sequence in seven Brazilian children associated with misoprostol use in the first trimester of pregnancy
27. Congenital malformation of the scalp and cranium after failed first trimester abortion attempt with misoprostol
28. Use of misoprostol during pregnancy and Mobius' syndrome in infants
29. Mifepristone (RU 486) - A modulator of progestin and glucocorticoid action
30. Contragestion and other clinical applications of RU 486, an antiprogesterone as the receptor
31. Early pregnancy termination with mifepristone and misoprostol in the United States
32. Comparison of two doses of mifepristone in combination with misoprostol for early medical abortion: A randomised trial
33. Medical abortion
34. Low-dose mifepristone 200 mg and vaginal misoprostol for abortion
35. Acceptability and feasibility of early pregnancy termination by mifepristone-misoprostol. Results of a large multicenter trial in the United States
36. A comparison of medical abortion (using mifepristone and gemeprost) with surgical vacuum aspiration: Efficacy and early medical sequelae
37. Providing mifepristone-misoprostol medical abortion: The view from the clinic